Number of finishers by age group for women and men with the overall race times for each age group (HH:MM:SS). حسب Beat Knechtle (5504402)

الموضوعات:

The performance difference between the sexes (in percent) across age groups for split disciplines and overall race times. حسب Beat Knechtle (5504402)

الموضوعات:

Participants by event status and sex. حسب Beat Knechtle (5504402)

الموضوعات:

S1 Data - حسب Beat Knechtle (5504402)

الموضوعات:

Sex difference in swimming by split disciplines by the type of swim, bike, and run course. حسب Beat Knechtle (5504402)

الموضوعات:

Average split and overall race times (HH:MM:SS). حسب Beat Knechtle (5504402)

الموضوعات:

Split and overall race times for women and by age group. حسب Beat Knechtle (5504402)

الموضوعات:

Trends of average and best race times for IRONMAN^® age group triathletes. حسب Beat Knechtle (5504402)

الموضوعات:

The results of digital inclusion affecting sense of security. حسب Lijuan Zhao (1387689)

الموضوعات:

S2 Data - حسب Beat Knechtle (5504402)

الموضوعات:

Number of finishers by sex and men-to-women ratio over the years between 2002 and 2022. حسب Beat Knechtle (5504402)

الموضوعات:

The educational differences in marginal effect of digital inclusion. حسب Lijuan Zhao (1387689)

الموضوعات:

The relative importance by dominance analysis. حسب Lijuan Zhao (1387689)

الموضوعات:

Summary results of the samples. حسب Lijuan Zhao (1387689)

الموضوعات:

Description of digital inclusion. حسب Lijuan Zhao (1387689)

الموضوعات:

Split and overall IRONMAN^® race times histograms for women and men. حسب Beat Knechtle (5504402)

الموضوعات:

Men-to-women ratio across age groups. حسب Beat Knechtle (5504402)

الموضوعات:

CSS data for this study. حسب Lijuan Zhao (1387689)

الموضوعات:

Trend of the sex difference across years in overall race time. حسب Beat Knechtle (5504402)

الموضوعات:

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides حسب Zufang Ba (11036420)

"…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …"